Quality by design with a focus on biosimilars
Pharmaceutical Technology
OCTOBER 28, 2022
For companies in the US, if the results show bioequivalence, an abbreviated new drug application (ANDA) containing the results is sent to the FDA to review and potentially approve. Even minor amounts of biological contaminants in your sample could cause unwanted biological effects,” Dr Amiji says.
Let's personalize your content